OTP to Host Patient-Focused Webinar on Advancing CGT Product Development
January 02, 2025
FDA’s Center for Biologics Evaluation and Research, Office of Therapeutic Products (OTP), will host a
patient-focused webinar on Jan. 30 to discuss its initiatives to advance cell and gene therapy (CGT) product development through innovation, collaboration and engagement.
Nicole Verdun, MD, OTP’s super office director, will join other leaders to share updates on the office’s efforts to address the rapid growth of CGT. The program will also address OTP’s goals, priorities and activities for 2025 and information on OTP’s patient engagement and outreach initiatives.
The webinar will take place 1-2 p.m. ET.
Registration is open to the public but required to attend.
